Stephen C. Benoit
Directeur Général chez Metabolic Solutions Development Co. LLC
Profil
Mr. Stephen C.
Benoit is a Chief Executive Officer & Director at Metabolic Solutions Development Co. LLC, a Member at Alpha Sigma Nu and a President, Chief Executive Officer & Director at MDI Therapeutics, Inc. He is on the Board of Directors at Metabolic Solutions Development Co. LLC and MDI Therapeutics, Inc.
Mr. Benoit was previously employed as a President & Chief Executive Officer by NanoMed Pharmaceuticals, Inc., a Principal by Bank of America Corp., a President & Chief Operating Officer by Global Food Protection Institute, a Member-Executive Management Committee by Kellanova, and a Vice President-Sales & Marketing by Sciona, Inc.
He received his undergraduate degree from Loyola Marymount University and an MBA from Loyola Marymount University.
Postes actifs de Stephen C. Benoit
Sociétés | Poste | Début |
---|---|---|
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Directeur Général | - |
Alpha Sigma Nu | Corporate Officer/Principal | - |
MDI Therapeutics, Inc.
MDI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MDI Therapeutics, Inc. engages in pharmaceuticals company. It focuses on developing small molecule PAI-1 inhibitors for the treatment of fibrosis. The company was founded by Daniel A. Lawrence in 2015 and is headquartered in Novi, MI. | Directeur Général | - |
Anciens postes connus de Stephen C. Benoit
Sociétés | Poste | Fin |
---|---|---|
Global Food Protection Institute
Global Food Protection Institute Miscellaneous Commercial ServicesCommercial Services The Global Food Protection Institute provides an intellectual and organizational umbrella for three distinct food protection initiatives. The American company was founded by Stephen C. Benoit. | Fondateur | - |
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | - |
NanoMed Pharmaceuticals, Inc.
NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Directeur Général | - |
KELLANOVA | Corporate Officer/Principal | - |
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Sales & Marketing | - |
Formation de Stephen C. Benoit
Loyola Marymount University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
KELLANOVA | Consumer Non-Durables |
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
Entreprise privées | 6 |
---|---|
NanoMed Pharmaceuticals, Inc.
NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Health Technology |
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Health Technology |
Alpha Sigma Nu | |
Global Food Protection Institute
Global Food Protection Institute Miscellaneous Commercial ServicesCommercial Services The Global Food Protection Institute provides an intellectual and organizational umbrella for three distinct food protection initiatives. The American company was founded by Stephen C. Benoit. | Commercial Services |
MDI Therapeutics, Inc.
MDI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MDI Therapeutics, Inc. engages in pharmaceuticals company. It focuses on developing small molecule PAI-1 inhibitors for the treatment of fibrosis. The company was founded by Daniel A. Lawrence in 2015 and is headquartered in Novi, MI. | Health Technology |